您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

SCITEK INTERNATIONAL (H.K.) LIMITED
Email: sciteck.hongkong@gmail.com
 

当前本网站药物产品种数共 8524 处方药 8148 非处方药 269 保健品/医疗用具 107

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 作用于消化系统药物->减肥药物
处方药:非处方药
包装规格: 60粒/盒
计价单位:
  点击放大  
生产厂家中文参考译名:
葛兰素史克
生产厂家英文名:
GlaxoSmithKline
该药品相关信息网址1:
http://www.myalli.com
原产地英文商品名:
Alli Weight Loss Aid Starter Pack 60ea/box
原产地英文药品名:
Orlistat
中文参考商品译名:
爱丽减肥起始装 60粒/盒
中文参考药品译名:
奥利司他
曾用名:
艾里,爱丽
原产地国家批准上市年份:
2007/02/07
英文适应病症1:
Weight Loss Aid
临床试验期:
完成
中文适应病症参考翻译1:
减肥
药品信息:

友情提示:Alli Weight Loss Aid Starter Pack 60ea/box没有销售!

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201221217321916.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文爱丽处方资料(仅供参考)

在加利福尼亚圣安东尼奥市的一家Walgreens药店,葛兰素史克公司生产的非处方降脂药在上架后四小时就快要被卖光了,《洛杉矶时报》报道说。“我一生中从没经历过此类事情。”该药店的药剂师说,“最近唯一一次抢购热潮是在9.11事件后人们因担心患炭疽热而抢购抗生素西普乐。”
本周葛兰素史克公司将推出一种叫Alli的药物,它是罗氏公司生产的赛尼可的翻版,但以非处方药的方式进行销售,Alli能抑制高热量脂肪在肠道的吸收。极度渴求减肥的消费者正对该药进行抢购。在drugstore.com网站上,九十粒装的Alli价格为62.99美元,葛兰素史克公司说目前该药可在全国各地的大药店、超市和折扣店里买到。
但减肥药有一段错综复杂的历史,在服用减肥药之初的兴奋劲过后随之而来的是其副作用。安非他明抑制食欲的作用使它成为六十年代人们首选的减肥药,但该药被大量滥用。政府调节机构和医生在七十年代取缔了安非他明。九十年代流行的减肥药cocktail fen-phen可能引起心脏瓣膜损害,为此惠氏公司在1997年将Pondimin和 Redux两种药退市后花费超过二百一十亿美元用于处理相关事宜和支付诉讼费用。
Alli虽不会威胁生命,但其最大的缺陷是能影响消费者的日常生活。在今年年初批准Alli上市后,FDA委婉警告消费者说:“该产品最常见的副作用是能改变肠道习性,包括排稀便。”葛兰素史克公司称该问题是治疗效果的一种体现,但他们直率的提醒消费者:“你也许会有一种急迫地想上厕所的感觉。在你感受到该药的治疗作用前,穿黑色的裤子并在工作时随身带一套替换衣服不失为一明智之举。”
一名药店经理告诉《洛杉矶时报》记者说,药品的副作用并不是消费者关心的内容。“它真的有效吗?”这是消费者咨询的
美国减肥新药alli上架开卖 副作用拉肚子
想贪口福又不必为卡路里付出代价?美国食品及药物管理局第一个核准不需处方笺的减肥药alli,今天在美国上架开卖。这个药物主要是藉由减低脂肪的吸收,达到减重的目的,不过旧金山史丹佛大学的营养专家认为,如果使用者不改变饮食习惯,一旦停止服药,体重仍会弹回来。
药罐里装着的白色胶囊alli,音同「艾里」,是第一个正式由美国食品及药物管理局批准,容许放在开架式药架公开贩售的减肥药。
旧金山南湾一家连锁药房前一天也进货开卖,他们的做法不是放在架上而是置于药剂部,客人经谘询过药剂师才放行购买,药剂师杰生告诉中央社记者有不少客人上门,清一色是中年女性。
除了服用减肥药,这位药剂师并对购买者加一句叮咛:「少吃、多运动」。
由葛兰素史克药厂推出的alli,新手包有三种份量:六十、九十和一百五十颗,一天服用三颗的价位是一点八美元。在新手包的透明盒子里,除了药罐,随身携带的蓝色药盒,还包括减重小偏方和低卡食谱的课程。
根据美国食品及药物管理局网站的新闻资料,今年二月七日核准的alli含有的成分奥利司他 (Orlistat),一天吃三颗,可以让肠胃减少吸收百分之二十五的脂肪。这和一九九九年上市的处方笺减肥药「让你酷」(Xenical)成分相同,新药alli剂量只有一半。
基本上,这个药物有两个用途:一是阻碍脂肪的吸收,二是制造不舒服的副作用,会让人不想吃脂肪高的食物。原本已采低脂饮食的人可能无法从中得到效果。
美国食品卫生管理局的临床研究发现,使用Alli配合饮食与运动,六个月可减轻百分之五的体重。
但是美国食品及药物管理局也表示,服用alli会有副作用,像腹痛、拉肚子,因此十八岁以下不能服用,有肾脏疾病、孕妇和授乳妇女等都不能服用。
虽有美国食品及药物管理局的背书,这家公司的网站并不敢说这是神奇药丸,提醒使用者仍必须配合运动、减低卡路里和采取低脂饮食。
旧金山地区的媒体「旧金山纪事报」和「圣荷西水星报」,这两天都有相关的报导。
旧金山的肥胖专家认为,这个药物安全,但建议最好和医生讨论,合并补充脂溶性维他命A和D。
十四日的旧金山纪事报引用加州大学旧金山分校临床研究员兼医师卡纳雅的说法指出,「并不是所有的脂肪都对人体不好,但是这个药并没有聪明到可以分别什么是好的或不好的脂肪。」
Alli不是肥胖症的万灵丹。根据十五日的圣荷西水星报,史丹佛大学医学院营养研究员贾德纳指出,如果一个人吃减肥药,但是不改变饮食习惯,药物阻断了吃进去的脂肪最终会达到减肥的目的,但是一旦停止用药,因为饮食习惯如常,所以脂肪又被吸收进身体,体重一定会弹回来。
Alli含的奥利司他成分会让使用者频频拉肚子,甚至无法控制,有经验的人在网路上留言建议,「服用者最好携带备份的裤子」。
根据研究,在美国百分之六十五的成人不是超重就是过胖,肥胖似乎是美国的国病,看准了这个市场,葛兰素史克药厂,预期至少第一年将花费一亿五千万美元行销,包括电视和杂志广告。
知名的芬芬(fen-phen)减肥药曾导致心瓣膜损害,于一九九七年下架。而美国食品及药物管理局稍早在这个星期,曾拒绝「Acomplia」减肥药的通过,该药已在欧洲核准,但是有导致自杀倾向的疑虑。
--------------------------------------------------------------------

非处方减肥药Alli (orlistat) 问世

转载自生命时报

据美联社消息,美国食品和药品管理局近日批准奥利司他(Alli, orlistat)作为第一个非处方减肥药。
目前市面上使用的西药减肥产品,主要有三类: 
神经递质再摄取抑制剂,以西布曲明为代表。作用于中枢神经系统,能降低服药者摄取食物的欲望。但可能会导致血压上升、脉搏增快,及心电图异常等。因此一些国家规定,必须有内分泌、心内科专家的处方才能使用。 
脂酶抑制剂,在胃及小肠中与胰脂酶结合,从而抑制脂肪的吸收。最新的试验显示,它不仅可以减轻体重,还能降低血压、胆固醇,缩小腰围。奥利司他即属于此类药物。 
芬氟拉明,作用机制目前尚不清楚,可能与大脑中5?羟色胺浓度或转换率降低有关,也可能是增加葡萄糖的利用。但可能会导致心瓣膜异常及原发性肺动脉高压,因此很多国家目前禁止使用这类药。 
奥利司他和目前临床上正在使用的处方减肥药赛尼可属于同一类药物,但剂量只有后者的一半。这类药物主要适用于体型肥胖的成人,通过抑制肠道中脂肪的吸收,使摄入脂肪的1/4从大便中排泄出去。服药中,如果辅以低热量、低脂饮食,并且配合适当的体育锻炼,减肥效果则更加明显。 
 不过,在临床试验中,研究者发现此类药物会在一定程度上影响脂溶性维生素的吸收。而且,约有半数的病人会出现不同程度的脂肪泻,并伴有排便习惯的改变。但是,如果改为低脂饮食,则可以减少这种不良反应。
--------------------------------------------------------------------------------------

转载Alli官方网站(http://www.myalli.com):

What is alli?
alli™ is the only FDA approved, over-the-counter weight loss product. The alli program includes alli capsules and myalliplan, an individually tailored, online action plan to help you lose weight gradually.
What makes alli different? FDA approval and a sensible approach that focuses on your long-term success.
alli isn’t just another product for you to buy. alli is a pill with a plan. This program requires a commitment to living your life in a new way as you learn to change your eating and activity habits.
alli is not for everyone, but alli is an option. If you are ready to take responsibility, alli and your hard work can help increase your weight loss by 50%. That means if you could lose 10 pounds with dieting alone, you could lose 15 pounds working with alli.
To find out if you’re ready for alli, take the alli weight loss readiness quiz.
Change is challenging
What’s so hard about taking a pill and following a plan? If you’ve ever tried to lose weight before, you know the hurdles. We’ve all heard the same thing for years: Eating a balanced diet and getting regular exercise are the starting points for any weight loss program.
In theory, that makes sense. In reality, it’s hard to do. Lots of people start a diet on Monday and get off track by lunch. They set a goal to only eat 600 calories a day and plan to spend five days at the gym. But nobody can maintain that kind of regimen. And who wants to live like that? With alli, you have an option based on gradual and healthy progress.
How alli capsules work
First, let’s talk about the capsule. alli prevents your body from absorbing about a quarter of the fat you eat. Fat is more calorie-dense than carbs or protein. Just one gram of fat has more than double the calories of the same amount of protein or carbs. So if you eat a reduced-calorie, low-fat diet and use alli capsules, you can make a real difference in your weight as you limit the total number of calories that enter your system.
Using reference guides available in the alli starter pack and support online, you’ll learn how to plan meals that limit your fat intake, track your progress using alli weight loss resources, and get more physically active.
How myalliplan helps
alli capsules work in partnership with myalliplan, a plan of customized guidance designed specifically for use with alli. When you purchase alli, you can activate your free membership with myalliplan for access to special features, including:
       a personal myalliplan homepage, where you can view your goals and progress, your latest steps, your meal plan, and more
       interactive tools that help you discover hidden calories and fat in foods
      an online journal, so you can record your eating and exercise habits
       lessons from clinical experts in weight loss — people who know what you’re up against when you’ve had a stressful day or a strong craving
      healthy and delicious recipes, smart meal plans, shopping lists, a dining out guide – the tools you need to guide your choices and gain results
Following a reduced-calorie, low-fat diet is a great way to start, but participating in myalliplan can give you the added direction and practical advice you need to make every step count. And support is available 24 hours a day.
-------------------------------------------------------------

转载自GlaxoSmithKline:

First Nonprescription Diet Drug Alli Wins FDA Approval
2/8/2007
PITTSBURGH, Feb. 7 /PRNewswire-FirstCall/-- GlaxoSmithKline [NYSE:GSK] Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product orlistat 60 mg capsules for over-the-counter (OTC) use in the United States. GSK Consumer Healthcare will market OTC orlistat under the brand name alli(TM) (pronounced AL-eye). Approved for use by overweight adults in conjunction with a reduced-calorie, low-fat diet, alli helps people lose 50 percent more weight than with diet alone. alli is the only FDA-approved weight-loss product available to consumers without a prescription, and it is the first clinically-proven over- the-counter product to be combined with a comprehensive support program. alli is expected to be available in stores nationwide by summer 2007. This approval marks the start of an educational program that includes a series of resources online at myalli.com.
GSK Consumer Healthcare selected alli as the brand name because it conveys the concept of partnership with consumers in their weight-loss efforts. Consumers spend billions of dollars each year on fad diets, unproven miracle pills, and potentially unsafe weight-loss supplements that may not work. alli is the clinically proven option to these hyped, quick-fix products that mislead overweight adults away from weight-loss strategies that are backed by medical science. With alli, consumers have access to an individually tailored online action plan that provides support and the necessary tools to help them lose 50 percent more weight than with diet alone.
Caroline Apovian, M.D., Director of the Center for Nutrition and Weight Management at Boston Medical Center welcomed the FDA decision. "I applaud the alli program for stressing the importance of a reduced-calorie, low-fat diet in conjunction with a weight-loss medicine proven to be safe and effective. This lines up with research that shows even modest, gradual weight loss provides significant health benefits." Apovian adds, "More and more people each year -- now two-thirds of all American adults -- are overweight or obese and still gaining weight.
Desperate to lose this excess weight, people resort to all types of extreme methods that promise everything and deliver no real results. Extremely restrictive diets are unrealistic to maintain, even for a couple of weeks. Dieters end up gaining more weight than they initially lost. It's time consumers readjust their thinking to realize positive results."
Why alli is Different
Unlike other products on store shelves, alli is a proven medicine with a comprehensive support program. To help consumers get off to a successful start, the alli package will include Welcome and Companion Guides, a Guide to Healthy Eating, a Daily Journal, a Calorie and Fat Counter, Quick Fact Cards, and free access to an individualized online action plan at myalli.com.
"With alli, we're excited to offer a revolutionary approach to weight loss," says Steven L. Burton, Vice President, Weight Control, GlaxoSmithKline Consumer Healthcare. "alli is more than a pill -- it's a comprehensive program that works in conjunction with a sensible diet to increase weight loss. Because weight loss doesn't happen overnight, we're starting to educate consumers now about the importance of realistic expectations, gradual weight loss and lifestyle changes. That's the way to see results, and with alli, we know they can do it."
Starting today, GSK Consumer Healthcare will gear up production to have the product ready for shipment and in stores by the summer. The company is using this period to build awareness and understanding about the product and its intended user -- with the message -- alli is not for everyone. It's for the committed consumer who can follow a reduced-calorie, low-fat diet. For this consumer, alli will provide a unique, proven approach to weight loss, offering straight talk, educational tools and an online support program -- myalli.com.
How to Use alli
alli, the only FDA-approved weight-loss product soon to be available without a prescription, is indicated for weight loss in overweight adults 18 years and older when used along with a reduced-calorie, low-fat diet. The recommended dose of alli is one 60 mg capsule three times a day with meals containing fat.
Taken at meal-time, alli works by blocking about 25 percent of the fat in the food a person eats. Because of the way it works, alli must be used in conjunction with a reduced-calorie, low-fat diet containing about 15 grams of fat per meal. The guides and information supplied in the alli package help the consumer to control the amount of fat in their meals, and to follow an appealing, reduced-calorie, low-fat diet. Consuming a meal with too much fat, while taking alli, can result in bowel changes such as having an urgent need to use the bathroom. These changes, called treatment effects, generally occur in the first weeks of treatment, are not harmful, and can be managed by following the recommended diet with about 15 grams of fat per meal. Users should take a multivitamin once a day, at bedtime, because alli can reduce the absorption of some vitamins.
Safety and Efficacy
alli (60 mg orlistat capsules) is safe and effective when used as directed. As the most extensively studied weight-loss medication on the market, the safety and efficacy of orlistat is very well established. A higher dose of orlistat has been marketed as the prescription drug Xenical® (orlistat 120 mg capsules) in the U.S. since 1999 and is supported by nine years of worldwide use in 145 other countries. Orlistat experience in more than 25 million patient treatments and more than 100 clinical studies with more than 30,000 patients is unprecedented. One of these studies with Xenical is the four-year landmark XENDOS trial conducted by Roche, its inventor and manufacturer. This study is the longest study ever conducted for a weight-loss medicine.
Xenical (orlistat 120 mg capsules) will remain available by prescription for those who should be treated under the care of a physician. Xenical will continue to be manufactured and sold by Roche.
For more information on alli, go to myalli.com.
About Overweight and Obesity
Currently, approximately 65 percent of U.S. adults are overweight or obese, according to the National Institutes of Health. Research suggests that overweight individuals appear to be on the pathway to obesity.(i, ii) Overweight and obesity are associated with an increased risk of developing health problems such as hypertension, type 2 diabetes and heart disease.(iii) Factors that can contribute to overweight include an abundance of high-calorie foods, low levels of physical activity, behavior, environment, and genetics.(iv) Multiple studies have shown that a modest reduction in weight improves health outcomes significantly in overweight or obese patients.(v, vi)
About GlaxoSmithKline Consumer Healthcare
GSK Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette®, NicoDerm® CQ and Commit® as well as many medicine cabinet staples, including Abreva®, Aquafresh®, Sensodyne®, Tums® and Breathe Right®.
About GlaxoSmithKline
GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.
Cautionary statement regarding forward-looking statements
Under the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995, the company cautions investors that any forward-looking statements or projections made by the company, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect the Group's operations are described under 'Risk Factors' in the Operating and Financial Review and Prospects in the company's Annual Report 2004.
(i) Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
(ii) McTigue KM, Garrett JM, Popkin BM. The natural history of the development of obesity in a cohort of young US adults between 1981- 1998. Ann Intern Med 2002;136:857-864.
(iii) Centers for Disease Control and Prevention: "Overweight and Obesity." http://www.cdc.gov/nccdphp/dnpa/obesity/. Accessed 12/22/05.
(iv) Centers for Disease Control and Prevention. "Overweight and Obesity: Contributing Factors." http://www.cdc.gov/nccdphp/dnpa/obesity/contributing_factors.htm. Accessed 12/22/05.
(v) Hauptman J, Lucas C, Baldrin MN, Collins H, Segal K. "Orlistat in the long-term treatment of obesity in primary care settings." Archives of Family Medicine 9:160-167.
(vi) NIH, NHLBI. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. HHS, PHS; 1998. p. 29-41.
Source: GlaxoSmithKline Consumer Healthcare

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201221217321916.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2012-2-13
附件:
 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:sciteck.hongkong@gmail.com, 15901965168@163.com